參考文獻(xiàn)/References:
[1] WATTS N B,CAMACHO P M,LEWIECKI E M,et al.American association of clinical endocrinologists/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update[J].Endocr Pract,2021,27(4):379-380.
[2] 中華醫(yī)學(xué)會骨質(zhì)疏松和骨礦鹽疾病分會.原發(fā)性骨質(zhì)疏松癥診療指南(2017)[J].中國骨質(zhì)疏松雜志,2019,25(3):281-309.
[3] HOFBAUER L C,RACHNER T D.More DATA to guide sequential osteoporosis therapy[J].Lancet,2015,386(9999):1116-1118.
[4] CAI X,YI X,ZHANG Y,et al.Genetic susceptibility of postmenopausal osteoporosis on sulfide quinone reductase-like gene[J].Osteoporos Int,2018,29(9):2041-2047.
[5] 中華醫(yī)學(xué)會骨質(zhì)疏松和骨礦鹽疾病分會.中國骨質(zhì)疏松癥流行病學(xué)調(diào)查及“健康骨骼”專項(xiàng)行動結(jié)果發(fā)布[J].中華骨質(zhì)疏松和骨礦鹽疾病雜志,2019,12(4):317-318.
[6] 梁文娜,李西海,李燦東.絕經(jīng)后骨質(zhì)疏松的核心病機(jī)——骨痿[J].中國老年學(xué)雜志,2015,35(18):5333-5335.
[7] 中華中醫(yī)藥學(xué)會.絕經(jīng)后骨質(zhì)疏松癥(骨痿)中醫(yī)藥診療指南(2019年版)[J].中醫(yī)正骨,2020,32(2):1-13.
[8] 張文達(dá),任艷玲.絕經(jīng)后骨質(zhì)疏松癥病因病機(jī)研究概況[J].遼寧中醫(yī)藥大學(xué)學(xué)報,2019,21(7):101-104.
[9] 李建國,謝興文,李寧,等.絕經(jīng)后骨質(zhì)疏松癥的中醫(yī)臟腑認(rèn)識及治療現(xiàn)狀[J].中國中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志,2019,25(3):410-412.
[10] 曹盼舉,張曉剛,于海洋,等.基于中醫(yī)學(xué)“肺與大腸相表里”理論的腸道微生態(tài)與骨質(zhì)疏松癥的關(guān)系探討[J].時珍國醫(yī)國藥,2019,30(10):2457-2459.
[11] 馮歆,葛繼榮.中醫(yī)從脾論治原發(fā)性骨質(zhì)疏松癥的研究進(jìn)展[J].中國骨質(zhì)疏松雜志,2014,20(8):968-972.
[12] SAKAMOTO S,SASSA S,KUDO H,et al.Preventive effects of a herbal medicine on bone loss in rats treated with a GnRH agonist[J].Eur J Endocrinol,2000,143(1):139-142.
[13] OU L,WEI P,LI M,et al.Inhibitory effect of Astragalus polysaccharide on osteoporosis in ovariectomized rats by regulating FoxO3a /Wnt signaling pathway[J/OL].Acta Cir Bras,2019,34(5):e201900502[2021-04-06].https://doi.org/10.1590/s0102-865020190050000002.
[14] ZHANG N D,HAN T,HUANG B K,et al.Traditional Chinese medicine formulas for the treatment of osteoporosis:Implication for antiosteoporotic drug discovery[J].J Ethnopharmacol,2016,189:61-80.
[15] HUANG X H,LIANG R H,SU L,et al.Mechanism of Bushen Jianpi decoction in preventing and treating osteoporosis caused by aromatase inhibitors in breast cancer treatment[J].Cancer Biomark,2017,18(2):183-190.
[16] 張邵青,邱美榕,吳追樂.“治痿獨(dú)取陽明”的古今研究及臨床應(yīng)用[J].陜西中醫(yī)藥大學(xué)學(xué)報,2016,39(2):9-12.
[17] 劉玥,張允嶺.淺論“治痿獨(dú)取陽明”[J].環(huán)球中醫(yī)藥,2014,7(9):713-715.
[18] 黃煜.“治痿獨(dú)取陽明”的異病同治思想——糖尿病性胃輕癱與“痿”的關(guān)系[J].中國中醫(yī)藥現(xiàn)代遠(yuǎn)程教育,2020,18(17):55-57.
[19] 曹繼忠,溫川飆.痿證之“治痿獨(dú)取陽明”淺析[J].世界最新醫(yī)學(xué)信息文摘,2018,18(92):205-206.
[20] 鞠申丹,宗蕾.從“治痿獨(dú)取陽明”談痿證的針灸治療[J].中國針灸,2015,35(9):956-959.
[21] 鄒桂芝,郝建軍,張介眉.張介眉教授運(yùn)用“治痿獨(dú)取陽明”臨證心得[J].實(shí)用中西醫(yī)結(jié)合臨床,2017,17(9):124-125.
[22] 胡湘玲.針刺對絕經(jīng)后骨質(zhì)疏松患者骨密度及血清雌二醇的影響[J].湖南中醫(yī)雜志,2016,32(11):86-87.
[23] 李碩,張玉珠,劉鈞雨,等.針刺聯(lián)合健脾益腎方治療脾腎虧虛型骨質(zhì)疏松癥療效觀察[J].中醫(yī)藥臨床雜志,2020,32(9):1771-1774.
[24] 李少華,康石發(fā),孫堅鋼,等.穴位貼敷療法治療絕經(jīng)后及老年性骨質(zhì)疏松癥腰背疼痛的研究進(jìn)展[J].中醫(yī)正骨,2020,32(5):43-45.
相似文獻(xiàn)/References:
[1]李林軍.應(yīng)用膨脹式椎弓根螺釘內(nèi)固定治療合并骨質(zhì)疏松的
胸腰椎退行性疾病[J].中醫(yī)正骨,2015,27(08):49.
[2]李學(xué)朋,朱立國.骨疏康膠囊對去卵巢大鼠骨小梁的影響[J].中醫(yī)正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康膠囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):12.
[3]陳冠軍,陳揚(yáng),莊汝杰.可灌注骨水泥椎弓根螺釘系統(tǒng)
在老年腰椎疾患手術(shù)中的應(yīng)用[J].中醫(yī)正骨,2015,27(02):40.
[4]王丹輝,賁越,韓梅.林蛙油治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):27.
[5]黃建華,黃建武,李慧輝,等.加味左歸丸對絕經(jīng)后骨質(zhì)疏松癥肝腎不足證
患者骨密度的影響[J].中醫(yī)正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(08):19.
[6]項(xiàng)旻,楊虹,林愛菊,等.絕經(jīng)后2型糖尿病患者骨質(zhì)疏松與血微量元素的關(guān)系研究[J].中醫(yī)正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(08):20.
[7]史曉林,李春雯,張志強(qiáng).弱陽離子磁珠分離技術(shù)和基質(zhì)輔助激光解吸電離飛行時間質(zhì)譜技術(shù)在原發(fā)性Ⅰ型骨質(zhì)疏松癥血清標(biāo)志蛋白篩選中的應(yīng)用[J].中醫(yī)正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):5.
[8]李明,徐明雄,馮左基,等.自擬壯骨方治療絕經(jīng)后骨質(zhì)疏松癥的療效及作用機(jī)制研究[J].中醫(yī)正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):21.
[9]陳俊杰,李晴晴,夏瑢.脂代謝及血清內(nèi)脂素水平與絕經(jīng)后骨質(zhì)疏松癥的
相關(guān)性研究[J].中醫(yī)正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(08):16.
[10]許超,肖魯偉,吳承亮.絕經(jīng)后女性骨質(zhì)疏松癥辨證分型與抑郁焦慮的關(guān)系研究[J].中醫(yī)正骨,2011,23(12):3.
XU Chao*,XIAO Lu-wei,WU Cheng-liang.*.Study on the relationship between the syndrome differ classification and the depression and anxiety for the postmenopausal women with osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(08):3.
[11]韓艷,溫利平,劉娜,等.補(bǔ)腎活血方對去卵巢大鼠骨代謝及骨密度的影響[J].中醫(yī)正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(補(bǔ)腎活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):7.
[12]歐國峰,劉鑫,董博,等.絕經(jīng)后骨質(zhì)疏松癥的免疫學(xué)研究進(jìn)展[J].中醫(yī)正骨,2016,28(08):70.
[13]施振宇,劉鐘,陳文亮,等.中醫(yī)綜合療法防治絕經(jīng)后骨量減少的多中心臨床研究[J].中醫(yī)正骨,2017,29(04):1.
SHI Zhenyu,LIU Zhong,CHEN Wenliang,et al.A multicenter clinical study of complex therapy of traditional Chinese medicine for prevention and treatment of postmenopausal osteopenia[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(08):1.
[14]梁文娜,李西海,李燦東.血清microRNA與絕經(jīng)后骨質(zhì)疏松癥腎虛證的關(guān)系[J].中醫(yī)正骨,2017,29(10):53.
[15]梁文娜,李西海,胡柳,等.二至丸抑制絕經(jīng)后骨質(zhì)疏松大鼠骨代謝紊亂的作用機(jī)制研究[J].中醫(yī)正骨,2017,29(11):1.
LIANG Wenna,LI Xihai,HU Liu,et al.Study on mechanism of action of Erzhi Wan(二至丸)in inhibiting bone metabolism disorder in rats with postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(08):1.
[16]劉晨,李興勇,姚興璋,等.絕經(jīng)后骨質(zhì)疏松癥的流行病學(xué)概況及發(fā)病機(jī)制研究進(jìn)展[J].中醫(yī)正骨,2018,30(03):52.
[17]楊依然,劉鐘,毛一凡,等.酪蛋白激酶-2相互作用蛋白1基于磷脂酰肌醇3-激酶/蛋白激酶B/哺乳動物雷帕霉素靶蛋白通路參與絕經(jīng)后骨質(zhì)疏松癥發(fā)生發(fā)展過程中細(xì)胞自噬的機(jī)制[J].中醫(yī)正骨,2018,30(04):59.
[18]曹俊青,鄭劍南,張麟.右歸丸聯(lián)合阿侖膦酸鈉口服治療絕經(jīng)后骨質(zhì)疏松癥腎陽虛證的臨床研究[J].中醫(yī)正骨,2018,30(05):20.
CAO Junqing,ZHENG Jiannan,ZHANG Lin.A clinical study of oral application of Yougui Wan(右歸丸)and alendronate sodium for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(08):20.
[19]李中萬,徐紹俊,楊廣鋼,等.健腎方聯(lián)合碳酸鈣D3咀嚼片(Ⅱ)
治療絕經(jīng)后骨質(zhì)疏松癥腎陽虛證[J].中醫(yī)正骨,2018,30(08):11.
LI Zhongwan,XU Shaojun,YANG Guanggang,et al.Oral application of Jianshen Fang(健腎方)and calcium carbonate and Vitamin D3 chewable tablets(Ⅱ)for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(08):11.
[20]趙凡,劉全,吳連國.口服強(qiáng)骨飲聯(lián)合碳酸鈣D3片治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2019,31(04):26.
ZHAO Fan,LIU Quan,WU Lianguo.Oral applications of Qianggu Yin(強(qiáng)骨飲)and calcium carbonate and Vitamin D3 tablets for treatment of postmenopausal osteoporosis:a clinical study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(08):26.